Intrinsic Value of S&P & Nasdaq Contact Us

HeartBeam, Inc. BEATW NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
44/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

HeartBeam, Inc. (BEATW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Analysts estimate Earnings Per Share (EPS) of $-0.73 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.73 vs est $-0.73 (beat +0%). 2025: actual $-0.62 vs est $-0.61 (missed -1.2%). Analyst accuracy: 99%.

EPS Estimates — BEATW

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.73 vs Est –$0.73 ▼ 0.0% off
2025 Actual –$0.62 vs Est –$0.61 ▼ 1.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — BEATW

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message